Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Life Tech, Douglas Sign Deal

By Drug Discovery Trends Editor | July 24, 2012

Life Technologies Corporation and Douglas Scientific LLC announced they have signed a collaboration and co-marketing agreement to optimize technologies from both companies and provide seamless solutions designed for high-throughput genotyping applications. This collaboration will leverage Life’s industry-leading TaqMan Assays and Douglas’s disruptive Array Tape Platform.

The growing demand for genetic marker screening has led to a greater need for high-throughput genotyping technology that can provide answers for researchers faster and more accurately with affordable, scalable solutions. While other systems enable genotyping of hundreds of samples, combining the TaqMan SNP Genotyping Assays and Array Tape Platform allows customers to easily generate hundreds of thousands of data points per day.

“Taqman is one of the most widely used assays for SNP genotyping. Optimizing the Array Tape Platform for this chemistry was a natural fit for our markets and applications,” says Dan Malmstrom, President and COO at Douglas Scientific. “With preset protocols and optimized instrumentation our customers will realize their throughput and economic goals while experiencing improvements in efficiency and data quality.”

The level of throughput and accuracy reached by combining these technologies is of particular benefit to the plant agricultural biotechnology and animal breeding industries for marker-assisted selection experiments. Genetic selection methods are now essential to enable these industries to keep pace with the food demands of the growing global population. Other animal, human and drug discovery research applications that require industrial-scale genotyping will also benefit from this powerful combination.

“The high throughput capacity of the Array Tape system is highly complementary to our real- time PCR portfolio, and in particular, our TaqMan Assays,” said Chris Linthwaite, Head of Genetic Analysis at Life Technologies. “Customers around the world can now leverage a complete solution for high-throughput genotyping – from sample prep to TaqMan Assays and the Array Tape system, which together offer the industry’s highest quality solution at the affordable cost and high throughput they need.”

Array Tape is a continuous polypropylene strip, serially embossed with reaction wells in customized volumes and formats. With miniaturized reaction wells, this thin (0.3 mm) and flexible solution allows 200 microplate equivalents (76,800 reaction wells) to be spooled onto a single, compact reel. It’s an automated, adaptable microplate replacement for high-throughput screening. Douglas Scientific provides inline, modular instrumentation that is fully integrated and optimized for use with Array Tape including: Nexar liquid handling and assay processing system, Soellex thermal cycler, Araya fluorescent detection instrumentation and software solutions. The platform enables a continuous reel-to-reel process flow to maximize throughput and reduce costs.

Life Technologies offers Custom TaqMan SNP Genotyping Assays for any species of interest.  The TaqMan portfolio also includes 4.5 million pre-designed TaqMan SNP Genotyping Assays ideally suited for biomarker screening applications and confirmatory studies following next-generation sequencing experiments. They are designed to accurately detect and quantify genetic variations in DNA samples associated with particular phenotypes of interest. The TaqMan portfolio also includes market-leading TaqMan Master Mix reagents and sample preparation kits such as the TaqMan Sample-to-SNP kit. They are part of a comprehensive portfolio of products and technologies to empower human, plant and animal sciences research.

Date: July 13, 2012
Source: Life Technologies Corporation and Douglas Scientific LLC


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE